| State-of-the-art behavioral and pharmacological treatments for alcohol use disorder LA Ray, S Bujarski, E Grodin, E Hartwell, RJ Green, A Venegas, AC Lim, ... The American journal of drug and alcohol abuse 45 (2), 124-140, 2019 | 107 | 2019 |
| Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co-and tri-use DJO Roche, S Bujarski, R Green, EE Hartwell, AM Leventhal, LA Ray Drug and alcohol dependence 200, 40-49, 2019 | 99 | 2019 |
| Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis LA Ray, RJ Green, DJO Roche, M Magill, S Bujarski Addiction biology 24 (6), 1138-1152, 2019 | 46 | 2019 |
| Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction: a randomized clinical trial LA Ray, RJ Green, C Enders, AM Leventhal, EN Grodin, G Li, A Lim, ... American Journal of Psychiatry 178 (9), 818-828, 2021 | 29 | 2021 |
| The interplay between subjective response to alcohol, craving, and alcohol self‐administration in the human laboratory RJ Green, E Grodin, AC Lim, A Venegas, S Bujarski, J Krull, LA Ray Alcoholism: Clinical and Experimental Research 43 (5), 907-915, 2019 | 26 | 2019 |
| Effects of varenicline on subjective craving and relative reinforcing value of cigarettes RJ Green, LA Ray Drug and alcohol dependence 188, 53-59, 2018 | 25 | 2018 |
| Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers SJ Nieto, EN Grodin, RJ Green, LA Ray Drug and Alcohol Dependence 221, 108603, 2021 | 23 | 2021 |
| Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers DJO Roche, S Bujarski, E Hartwell, RJ Green, LA Ray Pharmacology Biochemistry and Behavior 134, 92-98, 2015 | 21 | 2015 |
| Pharmacogenetic effects of naltrexone in individuals of East Asian descent: human laboratory findings from a randomized trial LA Ray, RJ Green, DJO Roche, S Bujarski, EE Hartwell, AC Lim, ... Alcoholism: Clinical and Experimental Research 42 (3), 613-623, 2018 | 19 | 2018 |
| Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity SJ Nieto, RJ Green, EN Grodin, CM Cahill, LA Ray Drug and alcohol dependence 218, 108368, 2021 | 18 | 2021 |
| Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder LA Ray, H Du, RJ Green, DJO Roche, S Bujarski Neuropsychopharmacology 46 (3), 519-527, 2021 | 17 | 2021 |
| Alcohol use disorder severity moderates clinical response to varenicline S Donato, RJ Green, LA Ray Alcoholism: Clinical and Experimental Research 45 (9), 1877-1887, 2021 | 14 | 2021 |
| Sex-dependent effects of alcohol administration on the urge to use cannabis. A Venegas, LR Meredith, RJ Green, ZD Cooper, LA Ray Experimental and clinical psychopharmacology 29 (6), 689, 2021 | 13 | 2021 |
| Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent AC Lim, DG Ghahremani, EN Grodin, RJ Green, S Bujarski, EE Hartwell, ... Drug and alcohol dependence 200, 181-190, 2019 | 12 | 2019 |
| Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses AC Lim, EN Grodin, R Green, A Venegas, LR Meredith, KE Courtney, ... The American journal of drug and alcohol abuse 46 (5), 565-576, 2020 | 11 | 2020 |
| Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving EE Hartwell, S Bujarski, RJ Green, LA Ray Addictive behaviors reports 10, 100198, 2019 | 10 | 2019 |
| Brain metabolite alterations related to alcohol use: a meta-analysis of proton magnetic resonance spectroscopy studies AE Kirkland, BD Browning, RJ Green, L Leggio, DJ Meyerhoff, ... Molecular Psychiatry 27 (8), 3223-3236, 2022 | 9 | 2022 |
| Ibudilast moderates the effect of mood on alcohol craving during stress exposure. LR Meredith, RJ Green, EN Grodin, M Chorpita, K Miotto, LA Ray Experimental and Clinical Psychopharmacology 30 (5), 620, 2022 | 6 | 2022 |
| Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology LR Meredith, EM Burnette, SJ Nieto, H Du, S Donato, EN Grodin, ... Alcohol: Clinical and Experimental Research 47 (9), 1629-1645, 2023 | 5 | 2023 |
| N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: a preliminary randomized clinical trial AE Kirkland, BD Browning, RJ Green, H Liu, AM Maralit, PL Ferguson, ... Neuropsychopharmacology 48 (8), 1184-1193, 2023 | 5 | 2023 |
